[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Conferences

Our Conferences articles contain the latest coverage of medical advancements from recent academic conferences.

Headlines All Categories Treatment AdvancesNavigating Your HealthCore EducationPatient StoriesHealthTree ResearchConferencesClinical TrialsHealthTree ProgramsHealthTree Press

Recent Articles

Evorpacept - A Next-Generation CD47 Inhibitor in Phase I Study for Patients With Relapsed-Refractory Lymphoma image

Evorpacept - A Next-Generation CD47 Inhibitor in Phase I Study for Patients With Relapsed-Refractory Lymphoma

May 06, 2024

newsletter icon

Get the latest thought leadership on your Mucosa-Associated Lymphoid Tissue Lymphoma delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.

Education

News Articles My Journal University Expert Webinars Find a Specialist HealthTree Podcast

Community

Connect Chapters Moves All Events

Cure Hub

HealthTree Cure Hub Find Side Effects Solutions See Tracked Labs Connect Medical Records Twin Machine Clinical Trial Finder

Get Involved

Create a fundraiser Tribute Donate Patient Surveys & Studies Connect Medical Records

About us

Our Story

Need Help?

Contact Us FAQ & Help Center 1-800-709-1113

Legal Info

Terms of Use Privacy Policy

Charity Navigator https://www.guidestar.org/profile/45-5354811

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2024 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811